Together we will beat cancer

Donate

Why consistent and funded cancer policies are key to improving cancer survival

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Read More

Stopping the spread: A revolution in how we think about metastasis

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

Read More

How “the most advanced machine learning approach” is finding new cancer-causing mutational signatures

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.  

Read More

Interpreted cancer awareness workshops: talking about cancer with South-Asian communities

One of our interpreted Talk Cancer workshops has been recognised in the Royal Society of Public Health’s, Health and Wellbeing awards 2022.

Read More

Why we need to continue to advocate for global tobacco control

This entry is part 2 of 3 in the series CRUK Global

In the last 2 years, our partner, the Nepal Development Research Institute, have successfully advocated for increases in tobacco tax in Nepal.

Read More

New targeted lung cancer screening programme on the horizon

Today, the UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those…

Read More

Health inequalities: breaking down barriers to cancer screening

This entry is part 4 of 4 in the series Health inequalities

In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening.

Read More

Life beyond cancer: Improving the long term side effects for children and young people with brain cancer

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

Read More

Looking back at a life-changing clinical trial

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

Read More

How our global activity is tackling cancer prevention in low- and middle-income countries

This entry is part 1 of 3 in the series CRUK Global

Focusing on cancer prevention globally is essential; we cannot say we have beaten cancer until we have beaten it everywhere.

Read More